Inventor · disambiguated record
Hidetomo Kitamura
Also filed as: KITAMURA HIDETOMO
17 granted patents·4 pending applications·298 citations·filing 1998–2024
94Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD9NAKAO KAZUWA3ITO HIROAKI2CHUGAI SEI YAKU KABUSHIKI KAIS1HASEGAWA MASAKAZU1
Top patents by PatentIndex Score
21 records- 0197US7320792B2Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonistCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Jan 22, 2008·147 cites·3 claims
- 0293US7642243B2Method of treating arthritis and promoting growth of articular chondrocytesNAKAO KAZUWA·Filed 2005·Granted Jan 5, 2010·36 cites·10 claims
- 0390US10544227B2Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 28, 2020·8 cites·12 claims
- 0490US8597644B2Method for treating psoriasis by administering an antibody to interleukin-6 receptorITO HIROAKI·Filed 2007·Granted Dec 3, 2013·16 cites·6 claims
- 0590US8562990B2Method of treating psoriatic arthritis with an IL-6 receptor antibodyITO HIROAKI·Filed 2011·Granted Oct 22, 2013·16 cites·16 claims
- 0687US9745378B2Antibodies that bind to cytokine receptor NR10CHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Aug 29, 2017·7 cites·20 claims
- 0786US8658373B2Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytesNAKAO KAZUWA·Filed 2009·Granted Feb 25, 2014·9 cites·14 claims
- 0885US6500854B1Chondrongenesis promotors and indolin-2-one derivativesCHUGAI SEI YAKU KABUSHIKI KAIS·Filed 2000·Granted Dec 31, 2002·27 cites·18 claims
- 0984US8431127B2Method for treating pruritus comprising administering an NR10 antagonistHIGUCHI YOSHINOBU·Filed 2008·Granted Apr 30, 2013·15 cites·19 claims
- 1083US11773173B2Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 3, 2023·2 cites·18 claims
- 1183US9028821B2Method of treating an inflammatory disease comprising administering an NR 10 antibody antagonistHASEGAWA MASAKAZU·Filed 2007·Granted May 12, 2015·8 cites·20 claims
- 1279US12441804B2Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Oct 14, 2025·0 cites·16 claims
- 1377US9993462B2Hydantoin derivative-containing pharmaceutical compositionCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Jun 12, 2018·3 cites·11 claims
- 1473US12077577B2Polypeptide comprising aggrecan binding domain and carrying moietyCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 3, 2024·1 cites·27 claims
- 1565US2024415624A1Tail vein injection system, tail vein injection method, and non-transitory computer-readable storage mediumPREFERRED NETWORKS INC·Filed 2024·Application pending·0 cites
- 1663US6716628B2Chondrogenesis promoters and indolin-2-one derivativesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Apr 6, 2004·2 cites·21 claims
- 1750US2004258731A1Preparation approriate for cartilage tissue formationFiled 2002·Application pending·0 cites
- 1850US2024209027A1Peptide and peptide-containing compositionPEPTIAID INC·Filed 2022·Application pending·0 cites
- 1946US2003187054A1Preparations for chondrogenesisFiled 2001·Application pending·0 cites
- 2036US8815803B2Method for increasing body height comprising systemic administration of CNP-53NAKAO KAZUWA·Filed 2005·Granted Aug 26, 2014·0 cites·5 claims
- 2131US7037717B1Cell line and screening method with the use of the sameCHUGAI PHARMACEUTICAL CO LTD·Filed 1998·Granted May 2, 2006·1 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →